(2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin
However, combining treatments should be done under medical supervision
Retatrutide (LY-3437943) is an investigational drug developed by Eli Lilly that acts as a triple hormone receptor agonist : GLP-1 (glucagon-like peptide-1) receptor agonist GIP (glucose-dependent insulinotropic polypeptide) receptor agonist Glucagon receptor agonist - read about why this is so important here This triagonist approach amplifies the metabolic impact seen with GLP-1 and GIP combinations like tirzepatide, while also leveraging glucagons thermogenic and energy-expending properties
If weight loss is slower (less than three pounds in two weeks) they may increase you to the next highest dose
If you take less than the recommended dose, you may have fewer side effects that week, but when you take your next shot, its as if youre starting over
Drinking plenty of water before, during, and after the dose increase helps your digestive system adjust and reduces nausea